Study shows higher relation between collagen I and II after autologus stem cell treatment. Collagen is the main supportive protein of cartilage, connective tissue, tendon, skin, and bone. It is a fibrous insoluble protein consisting of bundles of tiny reticular fibrils that combine to form the white glistening inelastic fibers of the tendons, the ligaments, and the fascia.
As per Science Daily its a stem cell surprise, and its being such a surprise that would divert the whole global stem cell thoughts and would overturn the previous stem cell researches.
Researchers at the University of California, Davis’ (UC Davis) recently openedResearchers at the University of California, Davis’ (UC Davis) recently opened horse stem-cell center expect to collaborate with human stem-cell researchers, as because presently veterinary medicine has stealthily taken the front state using stem cells harvested from marrow and fat.
Scientists claimed that they have found abundant source of mesenchymal stem cells peeping inside discarded fallopian tubes.
Texarkana neurosurgeons introduced an innovative stem cell procedure that could improve the desired results of surgical interventions of spinal cord injury and back pain.
Only a disable person knows the actual pain of the disability, she is Cody Unser a disabled disability activist, the global voice for disable person, student at University of Redlands and head of the Cody Unser First Step Foundation.
A unique tissue scaffold has been created by researchers from Cambridge-MIT Institute, that could offer a potential new treatment for sports injuries and other cartilage damage, such as arthritis.
NeoStem, Inc. got the right of it’s stem cell treatment procedure Regenexx™,from Regenerative Sciences. Regenexx procedure is a breakthrough, non-surgical treatment option for people suffering from moderate to sever bone pain due to injury and other conditions.
$5.8 Million stem research grant has been allowed by the California Institute for Regenerative Medicine(CIRM) to the researchers of Stanford University’s School of Medicine today to find and focus on ways to stimulate existing adult stem cells to heal damaged nerves, bone, skin and cardiac muscle.
Biotechnology firm Mesoblast has received approval at Melbourne’s Epworth hospital to commence a Phase 2 trial of its allogeneic, or “off-the-shelf”, cell therapy product for fusion of the cervical spine.